Colgate-Palmolive Company (CL) financial statements (2021 and earlier)

Company profile

Business Address 300 PARK AVE
NEW YORK, NY 10022
State of Incorp. DE
Fiscal Year End December 31
SIC 2844 - Perfumes, Cosmetics, and Other Toilet Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments888989997854883948863
Cash and cash equivalents888989997854883948863
Receivables1,2641,2921,2311,5511,4401,4951,590
Inventory, net of allowances, customer advances and progress billings1,6731,5781,5241,3011,4001,3711,322
Inventory1,6731,5781,5241,3011,4001,3711,322
Other current assets513508460542456535480
Total current assets:4,3384,3674,2124,2484,1794,3494,255
Noncurrent Assets
Property, plant and equipment3,7163,5063,4833,4873,7503,6893,793
Intangible assets, net (including goodwill)6,7186,5496,4156,3816,1756,0674,145
Goodwill3,8243,7113,6283,5593,5083,5322,536
Intangible assets, net (excluding goodwill)2,8942,8382,7872,8222,6672,5351,609
Deferred income tax assets291208224179177165167
Other noncurrent assets857836807775753756791
Total noncurrent assets:11,58211,09910,92910,82210,85510,6778,896
TOTAL ASSETS:15,92015,46615,14115,07015,03415,02613,151
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,1374,2164,0723,9333,5243,7263,777
Accounts payable1,3931,2251,1891,2161,2371,1881,209
Accrued liabilities2,3412,5682,3832,2321,9172,2922,275
Taxes payable403423500485370246293
Debt2672655085105145055
Total current liabilities:4,4044,4814,5804,4434,0384,2313,782
Noncurrent Liabilities
Long-term debt and lease obligation7,3346,9716,8847,3367,3337,6466,640
Long-term debt, excluding current maturities7,3346,9716,8847,3367,3337,6466,640
Liabilities, other than long-term debt3,0812,9412,9452,9503,1052,9752,739
Deferred income tax liabilities426406400415507587303
Other liabilities2,6552,5352,5452,5352,5982,3882,436
Total noncurrent liabilities:10,4159,9129,82910,28610,43810,6219,379
Total liabilities:14,81914,39314,40914,72914,47614,85213,161
Stockholders' equity
Stockholders' equity attributable to parent, including:743653268(113)117(324)(347)
Common stock1,4661,4661,4661,4661,4661,4661,466
Treasury stock, value(23,045)(22,280)(22,075)(22,104)(22,063)(21,900)(21,682)
Additional paid in capital2,9692,8372,6662,6232,4882,4662,338
Accumulated other comprehensive loss(4,345)(4,421)(4,519)(4,578)(4,273)(4,215)(4,119)
Retained earnings23,69923,05222,73122,48122,50121,86021,653
Other undisclosed stockholders' equity attributable to parent(1)(1)(1)(1)(2)(1)(3)
Stockholders' equity attributable to noncontrolling interest358420464454441498337
Total stockholders' equity:1,1011,073732341558174(10)
TOTAL LIABILITIES AND EQUITY:15,92015,46615,14115,07015,03415,02613,151

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues4,3244,1533,8974,0974,0153,9283,866
Cost of revenue(1,681)(1,613)(1,528)(1,632)(1,601)(1,612)(1,558)
Gross profit:2,6432,5402,3692,4652,4142,3162,308
Operating expenses(1,633)(1,518)(1,395)(1,473)(1,412)(1,429)(1,369)
Other operating expense, net(41)(4)(28)(40)(71)(31)(51)
Operating income:9691,018946952931856888
Nonoperating income (expense)(18)(15)(20)(21)18(27)(27)
Net periodic defined benefits expense (reversal of expense), excluding service cost component(18)(15)(20)(21) (27)(27)
Other undisclosed loss from continuing operations before equity method investments, income taxes(184)   (193)  
Income from continuing operations before equity method investments, income taxes:7671,003926931756829861
Other undisclosed income (loss) from continuing operations before income taxes127(36)(35)(36)114(35)(38)
Income from continuing operations before income taxes:894967891895870794823
Income tax expense(202)(222)(216)(147)(188)(167)(205)
Net income:692745675748682627618
Net loss attributable to noncontrolling interest(45)(47)(40)(33)(39)(49)(32)
Net income available to common stockholders, diluted:647698635715643578586

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income:692745675748682627618
Other comprehensive income (loss)8211261(321)(54)(102)36
Comprehensive income:774857736427628525654
Comprehensive loss, net of tax, attributable to noncontrolling interest(52)(59)(43)(17)(43)(43)(27)
Comprehensive income, net of tax, attributable to parent:722798693410585482627

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: